Experimental and in-host evolution of triazole resistance in human pathogenic fungi

Keyphrases

• Azole Resistance 100%
• Human Pathogenic Fungi 100%
• In-host 100%
• Candida 60%
• CYP51 60%
• Fumigatus 40%
• Drug Transporters 40%
• ERG11 40%
• Overexpression 20%
• Transcription Factor 20%
• Fungal Pathogens 20%
• Resistant Strains 20%
• Triazole 20%
• Systemic Infection 20%
• Ergosterol 20%
• Biosynthetic Pathway 20%
• Evolution Path 20%
• Molecular Approaches 20%
• Resistance mutations 20%
• Immunocompromised Patients 20%
• Aneuploidy 20%
• Copy number Variation 20%
• Proclivity 20%
• Aspergillus Fumigatus 20%
• Cryptococcus Neoformans 20%
• Pathogenic Fungi 20%
• Cytochrome P450 (CYP450) 20%
• Resistance Mechanisms 20%
• Full Potential 20%
• In Vitro Evolution 20%
• Genome Editing 20%
• Resistance Evolution 20%
• Fine Resolution 20%
• Cryptococcus Spp 20%
• Lanosterol 20%
• Omics 20%
• Experimental Facility 20%
• TAC1 20%
• Emerging Epidemics 20%
• Demethylase 20%
• Triazole-resistant 20%
• PDR5 20%
• Mrr1 20%
• Antifungal Resistant 20%
• Clinical Fungi 20%
• Resistant Fungi 20%

Immunology and Microbiology

• Pathogenic Fungi 100%
• Candida 100%
• Infectious Agent 33%
• Filobasidiella 33%
• Immunocompromised Patient 33%
• Mould 33%
• Biosynthesis 33%
• Transcription Factors 33%
• Aspergillus fumigatus 33%
• Cryptococcus neoformans 33%
• Gene Editing 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Triazole 100%
• Candida 50%
• Antifungal Agent 33%
• Effusion 33%
• Infection 16%
• Triazole Derivative 16%
• Infectious Agent 16%
• Filobasidiella 16%
• Immunocompromised Patient 16%
• Sepsis 16%
• Aspergillus fumigatus 16%
• Mould 16%
• Cryptococcus neoformans 16%
• Transcription Factors 16%
• Ergosterol 16%
• Lanosterol 14 Alpha-Demethylase 16%
• Cytochrome P450 16%
• Tamsulosin 16%
• Aneuploidy 16%